MeSH term
Frequency | Condition_Probility | Cell Line | 22 | 0.0 |
Drug Synergism | 2 | 0.0 |
Erythropoietin/*pharmacology | 2 | 1.0 |
Humans | 59 | 0.0 |
*Milk Proteins | 7 | 1.0 |
Transfection | 12 | 0.0 |
*Transcription Factors | 30 | 1.0 |
Binding Sites | 4 | 0.0 |
Carrier Proteins/physiology | 2 | 1.0 |
DNA-Binding Proteins/*metabolism | 9 | 0.0 |
*Intracellular Signaling Peptides and Proteins | 18 | 2.0 |
Proteins/physiology | 2 | 1.0 |
*Repressor Proteins | 33 | 2.0 |
Research Support, Non-U.S. Gov't | 47 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 14 | 0.0 |
*Signal Transduction | 7 | 0.0 |
Trans-Activators/*metabolism | 9 | 0.0 |
Gene Expression Profiling | 3 | 0.0 |
*Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Immunoprecipitation | 3 | 1.0 |
Mutation | 4 | 0.0 |
Oligonucleotide Array Sequence Analysis | 3 | 0.0 |
Phosphorylation | 23 | 0.0 |
Repressor Proteins/genetics/*metabolism | 2 | 1.0 |
Transcription Factors/genetics/*metabolism | 2 | 0.0 |
Tumor Cells, Cultured | 5 | 0.0 |
Base Sequence | 8 | 0.0 |
DNA Primers | 6 | 0.0 |
Membrane Glycoproteins/genetics/*metabolism | 3 | 1.0 |
Promoter Regions (Genetics) | 6 | 0.0 |
RNA, Messenger/genetics/metabolism | 3 | 0.0 |
Signal Transduction/*immunology | 3 | 0.0 |
Blotting, Western | 5 | 0.0 |
Carrier Proteins/genetics/*metabolism | 2 | 0.0 |
*DNA-Binding Proteins | 7 | 0.0 |
Female | 9 | 0.0 |
Pregnancy | 2 | 0.0 |
Proteins/genetics/*metabolism | 6 | 1.0 |
RNA, Messenger/metabolism | 5 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 6 | 0.0 |
*Trans-Activators | 6 | 0.0 |
Cell Line, Tumor | 4 | 0.0 |
English Abstract | 5 | 0.0 |
Carrier Proteins/*genetics | 2 | 0.0 |
Comparative Study | 7 | 0.0 |
Repressor Proteins/*genetics | 5 | 1.0 |
Transcription Factors/*genetics | 5 | 0.0 |
Animals | 35 | 0.0 |
Calcium/metabolism | 2 | 0.0 |
Cell Division | 2 | 0.0 |
Immunohistochemistry | 2 | 0.0 |
In Situ Hybridization | 2 | 0.0 |
Mice | 21 | 0.0 |
Mice, Inbred C57BL | 5 | 0.0 |
Protein Binding | 10 | 0.0 |
Proto-Oncogene Proteins/metabolism | 2 | 0.0 |
Time Factors | 7 | 0.0 |
Transcription Factors/metabolism | 4 | 0.0 |
Blotting, Northern | 7 | 0.0 |
Molecular Sequence Data | 6 | 0.0 |
Mutagenesis, Site-Directed | 3 | 0.0 |
Proteins/*genetics | 2 | 0.0 |
Repressor Proteins/*physiology | 2 | 1.0 |
Transcription, Genetic/drug effects/physiology | 2 | 5.0 |
Proteins/*metabolism | 4 | 0.0 |
Transcription, Genetic | 5 | 0.0 |
Carrier Proteins/*physiology | 2 | 0.0 |
Cytokines/metabolism | 3 | 0.0 |
Protein Structure, Tertiary | 4 | 0.0 |
Proteins/*physiology | 6 | 3.0 |
Signal Transduction | 20 | 0.0 |
Cytokines/*physiology | 2 | 1.0 |
Hydrolysis | 2 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Precipitin Tests | 4 | 0.0 |
Protein-Tyrosine Kinase/*metabolism | 3 | 0.0 |
Signal Transduction/*physiology | 7 | 0.0 |
Cell Nucleus/metabolism | 5 | 0.0 |
DNA-Binding Proteins/metabolism | 10 | 0.0 |
Gene Expression Regulation | 3 | 0.0 |
Genes, Reporter | 4 | 0.0 |
Immunoblotting | 4 | 0.0 |
Retroviridae/genetics | 3 | 0.0 |
Trans-Activators/metabolism | 10 | 1.0 |
Transcription Factors/*metabolism | 2 | 0.0 |
Carrier Proteins/metabolism | 4 | 0.0 |
Cytokines/*metabolism | 3 | 1.0 |
Flow Cytometry | 2 | 0.0 |
Ligands | 2 | 0.0 |
Mice, Inbred BALB C | 3 | 0.0 |
Protein-Tyrosine Kinase/metabolism | 7 | 0.0 |
Recombinant Proteins/chemistry | 2 | 0.0 |
Repressor Proteins/metabolism | 4 | 2.0 |
Spleen/metabolism | 2 | 1.0 |
*Up-Regulation | 2 | 0.0 |
DNA-Binding Proteins/drug effects/metabolism | 2 | 7.0 |
Amino Acid Sequence | 6 | 0.0 |
Amino Acid Substitution | 2 | 0.0 |
Rats | 6 | 0.0 |
Tyrosine/genetics/*metabolism | 3 | 13.0 |
Gene Expression | 3 | 0.0 |
Tyrosine/metabolism | 3 | 0.0 |
src Homology Domains | 7 | 1.0 |
Adult | 6 | 0.0 |
Antigens, CD/*metabolism | 2 | 0.0 |
Glutathione Transferase/metabolism | 2 | 0.0 |
Membrane Glycoproteins/*metabolism | 2 | 0.0 |
Recombinant Fusion Proteins/metabolism | 5 | 0.0 |
Tyrosine/chemistry | 2 | 1.0 |
Phosphotyrosine/metabolism | 2 | 0.0 |
*Proto-Oncogene Proteins | 6 | 0.0 |
*Protein Biosynthesis | 2 | 0.0 |
Proteins/genetics | 5 | 0.0 |
Enzyme Activation | 5 | 0.0 |
*src Homology Domains | 3 | 1.0 |
Tyrosine/*metabolism | 3 | 0.0 |
Cells, Cultured | 10 | 0.0 |
Interferon Type II/*pharmacology | 2 | 0.0 |
Interferon-alpha/*pharmacology | 2 | 1.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Cell Division/drug effects | 4 | 0.0 |
Male | 5 | 0.0 |
Up-Regulation | 2 | 0.0 |
RNA, Messenger/genetics | 3 | 0.0 |
Leukemia, Myelocytic, Acute/*genetics | 2 | 1.0 |
Middle Aged | 2 | 0.0 |
Down-Regulation | 2 | 0.0 |
Mitogen-Activated Protein Kinase 1/metabolism | 2 | 0.0 |
Mitogen-Activated Protein Kinase 3 | 2 | 0.0 |
Mitogen-Activated Protein Kinases/metabolism | 3 | 0.0 |
Carrier Proteins/genetics | 2 | 0.0 |
Interleukin-6/genetics/*metabolism | 4 | 22.0 |
Antineoplastic Agents/pharmacology | 2 | 0.0 |
Hamsters | 2 | 0.0 |
Kinetics | 2 | 0.0 |
Mice, Knockout | 2 | 0.0 |
Rats, Sprague-Dawley | 2 | 0.0 |
Mice, Transgenic | 3 | 0.0 |
Proteins/genetics/metabolism | 2 | 1.0 |
Protein Biosynthesis | 2 | 0.0 |
Antigens, CD/genetics/*metabolism | 2 | 2.0 |
Fibroblasts/cytology/physiology | 2 | 2.0 |
Receptors, Erythropoietin/genetics/metabolism | 2 | 18.0 |
Growth Hormone/pharmacology | 2 | 5.0 |
Models, Biological | 2 | 0.0 |
Carrier Proteins/genetics/metabolism | 2 | 1.0 |
